Search Results - "FINOCCHIARO, Gaetano"
-
1
Milan 2020: COVID-19, neuro-oncology and much more
Published in Journal of neuro-oncology (01-05-2020)Get full text
Journal Article -
2
Clonal evolution of glioblastoma under therapy
Published in Nature genetics (01-07-2016)“…Raul Rabadan, Antonio Iavarone, Gaetano Finocchiaro, Do-Hyun Nam and colleagues analyze longitudinal genomic and transcriptomic data from 114 patients with…”
Get full text
Journal Article -
3
The integrated landscape of driver genomic alterations in glioblastoma
Published in Nature genetics (01-10-2013)“…Anna Lasorella, Raul Rabadan, Antonio Iavarone and colleagues report an integrated analysis of genomic alterations in glioblastoma. They identify and…”
Get full text
Journal Article -
4
Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth
Published in Cell (17-11-2016)“…Glioblastoma stem cells (GSCs) are implicated in tumor neovascularization, invasiveness, and therapeutic resistance. To illuminate mechanisms governing these…”
Get full text
Journal Article -
5
MRI in Glioma Immunotherapy: Evidence, Pitfalls, and Perspectives
Published in Journal of immunology research (01-01-2017)“…Pseudophenomena, that is, imaging alterations due to therapy rather than tumor evolution, have an important impact on the management of glioma patients and the…”
Get full text
Journal Article -
6
A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma
Published in The oncologist (Dayton, Ohio) (01-04-2019)“…Background We assessed the efficacy and safety of bevacizumab (BEV) through multiple lines in patients with recurrent glioblastoma who had progressed after…”
Get full text
Journal Article -
7
High tumor mutational burden and T-cell activation are associated with long-term response to anti-PD1 therapy in Lynch syndrome recurrent glioblastoma patient
Published in Cancer Immunology, Immunotherapy (01-03-2021)“…Background Glioblastomas (GBMs) in patients harboring somatic or germinal mutations of mismatch-repair (MMR) genes exhibit a hypermutable phenotype. Here, we…”
Get full text
Journal Article -
8
Sox2 Is Required to Maintain Cancer Stem Cells in a Mouse Model of High-Grade Oligodendroglioma
Published in Cancer research (Chicago, Ill.) (15-03-2014)“…The stem cell-determining transcription factor Sox2 is required for the maintenance of normal neural stem cells. In this study, we investigated the requirement…”
Get full text
Journal Article -
9
Advanced neuroimaging studies: a patient-centered revolution
Published in Clinical and translational imaging : reviews in nuclear medicine and molecular imaging (03-08-2022)Get full text
Journal Article -
10
A regulatory circuit of miR-125b/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathways
Published in Nature communications (04-10-2016)“…Molecularly defined subclassification is associated with phenotypic malignancy of glioblastoma (GBM). However, current understanding of the molecular basis of…”
Get full text
Journal Article -
11
A radial glia gene marker, fatty acid binding protein 7 (FABP7), is involved in proliferation and invasion of glioblastoma cells
Published in PloS one (21-12-2012)“…Glioblastoma multiforme (GBM) is among the most deadly cancers. A number of studies suggest that a fraction of tumor cells with stem cell features (Glioma…”
Get full text
Journal Article -
12
The MET Oncogene Is a Functional Marker of a Glioblastoma Stem Cell Subtype
Published in Cancer research (Chicago, Ill.) (01-09-2012)“…The existence of treatment-resistant cancer stem cells contributes to the aggressive phenotype of glioblastoma. However, the molecular alterations that drive…”
Get full text
Journal Article -
13
Coexisting cancer stem cells with heterogeneous gene amplifications, transcriptional profiles, and malignancy are isolated from single glioblastomas
Published in Cell reports (Cambridge) (29-08-2023)“…Glioblastoma (GBM) is known as an intractable, highly heterogeneous tumor encompassing multiple subclones, each supported by a distinct glioblastoma stem cell…”
Get full text
Journal Article -
14
ERBB3 overexpression due to miR-205 inactivation confers sensitivity to FGF, metabolic activation, and liability to ERBB3 targeting in glioblastoma
Published in Cell reports (Cambridge) (27-07-2021)“…In glioblastoma (GBM), the most frequent and lethal brain tumor, therapies suppressing recurrently altered signaling pathways failed to extend survival…”
Get full text
Journal Article -
15
MET inhibition overcomes radiation resistance of glioblastoma stem‐like cells
Published in EMBO molecular medicine (01-05-2016)“…Glioblastoma (GBM) contains stem‐like cells (GSCs) known to be resistant to ionizing radiation and thus responsible for therapeutic failure and rapidly lethal…”
Get full text
Journal Article -
16
Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas
Published in Cancer research (Chicago, Ill.) (01-11-2006)“…Cancer stem-like cells (CSC) could be a novel target for cancer therapy, including dendritic cell (DC) immunotherapy. To address this, we developed experiments…”
Get full text
Journal Article -
17
Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8+ T cell activation in the presence of adjuvant temozolomide
Published in Oncoimmunology (03-04-2018)“…In a two-stage phase II study, 24 patients with first diagnosis of glioblastoma (GBM) were treated with dendritic cell (DC) immunotherapy associated to…”
Get full text
Journal Article -
18
Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
Published in The lancet oncology (01-11-2015)“…Summary Immunotherapy is a promising area of therapy in patients with neuro-oncological malignancies. However, early-phase studies show unique challenges…”
Get full text
Journal Article -
19
Extraneural metastases in glioblastoma patients: two cases with YKL-40-positive glioblastomas and a meta-analysis of the literature
Published in Neurosurgical review (2016)“…Glioblastoma (GBM) are high-grade gliomas that severely impact on overall survival (OS). GBM cell motility and the breakdown of the blood–brain barrier could…”
Get full text
Journal Article -
20
Targeting Post-Translational Modifications to Improve Combinatorial Therapies in Breast Cancer: The Role of Fucosylation
Published in Cells (Basel, Switzerland) (01-03-2023)“…Various tumors rely on post-translational modifications (PTMs) to promote invasiveness and angiogenesis and to reprogram cellular energetics to abate…”
Get full text
Journal Article